IdebenoneLack of efficacy and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1929卷 / 1期

关键词：

D O I：

10.1007/s40278-022-25959-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：335 / 335

相关论文

共 50 条

[41] Anakinra/prednisoloneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1907 (1) : 39 - 39
[42] RituximabLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1905 (1) : 444 - 444
[43] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1925 (1) : 347 - 347
[44] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1944 (1) : 395 - 395
[45] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1939 (1) : 319 - 319
[46] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1924 (1) : 309 - 309
[47] Multiple drugsLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 304 - 304
[48] AntineoplasticsNeutropenia, off-label use and lack of efficacy: case report
Reactions Weekly, 2022, 1926 (1) : 69 - 69
[49] Alteplase/dexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1935 (1) : 29 - 29
[50] Cangrelor/heparinLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1978 (1) : 112 - 112

← 1 2 3 4 5 →